Onconetix Inc risk profile
91 Acute at or past the historical limit
Measured 21 October 2026 from ONCO's filed statements. Recomputed nightly.
91 (Acute), driven by Competitive position at 100, over 3 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | Reads pct_below_52w_high, volatility_1y_pct and avg_turnover_90d_usd. No reading is stored for this company. | |||
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | Reads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company. | |||
| Leverage and coverage | 53 | Elevated | Easing | Interest cover — -23.76x |
| Competitive position | 100 | Acute | Stable | Operating-margin gap against peers — -2,047.8 percentage points |
| Concentration | 97 | Acute | Stable | Geographic concentration — 9,545 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.